Atomoxetine is the generic name for the brand-name medication Strattera, used to treat attention deficit hyperactivity disorder (ADHD) in children and adults.

Founded in 1977, Glenmark Pharmaceuticals distributes more than 110 drugs in the U.S. It serves about 65 countries through its range of product offerings and is ranked among the top 80 Pharma & Biotech companies in the world in terms of revenue. Glenmark has 15 manufacturing sites across the U.S., India, Argentina, and the Czech Republic.